Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;86(11):2111-2113.
doi: 10.1111/bcp.14359. Epub 2020 May 15.

Spotlight Commentary: What's new in lipid-lowering pharmacology? Integrating basic and clinical research to improve patient outcomes

Peter E Penson  1   2   3
Affiliations
Comment

Spotlight Commentary: What's new in lipid-lowering pharmacology? Integrating basic and clinical research to improve patient outcomes

Peter E Penson. Br J Clin Pharmacol. 2020 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr Penson owns four shares in AstraZeneca PLC and has received honoraria and/or travel reimbursement for events sponsored by AKCEA, Amgen, AMRYT, Link Medical, Napp and Sanofi.

Comment on

References

    1. Collins R, Reith C, Emberson J, et al. Interpretation of the evidence for the efficacy and safety of statin therapy. The Lancet. 2016;388(10059):2532‐2561. - PubMed
    1. Wang C, Zheng Q, Zhang M, Lu H. Lack of ethnic differences in the pharmacokinetics and pharmacodynamics of evolocumab between Caucasian and Asian populations. Br J Clin Pharmacol. 2019;85(1):114‐125. - PMC - PubMed
    1. Dimmitt SB, Stampfer HG, Warren JB. The pharmacodynamic and clinical trial evidence for statin dose. Br J Clin Pharmacol. 2018;84(6):1128‐1135. - PMC - PubMed
    1. Penson PE, Mancini GBJ, Toth PP, et al. Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions. J Cachexia Sarcopenia Muscle. 2018;9(6):1023‐1033. - PMC - PubMed
    1. Awad K, Mikhailidis DP, Toth PP, et al. Efficacy and safety of alternate‐day versus daily dosing of statins: a systematic review and meta‐analysis. Cardiovasc Drugs Ther. 2017;31(4):419‐431. - PubMed

MeSH terms

Substances